SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Titan Bio-Tech - Quaterly Results

12 Feb 2025 Evaluate
The sales for the December 2024 quarter moved down to Rs. 382.76 millions as compared to Rs. 459.79 millions during the year-ago period.Net profit of the cmpany stood at Rs. 38.02 millions for the quarter ended December 2024 a decline of -48.51% from Rs. 73.84 millions  in the same quarter last year.Operating Profit reported a sharp decline to 64.36 millions from 110.40 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 382.76 459.79 -16.75 1212.82 1241.53 -2.31 1640.72 1439.99 13.94
Other Income 15.90 4.37 263.84 25.33 12.71 99.29 17.48 19.43 -10.04
PBIDT 64.36 110.40 -41.70 233.88 284.74 -17.86 360.29 314.63 14.51
Interest 1.48 2.64 -43.94 7.23 8.30 -12.89 11.70 7.46 56.84
PBDT 62.88 107.76 -41.65 226.65 276.44 -18.01 348.59 307.17 13.48
Depreciation 11.83 8.35 41.68 33.26 24.91 33.52 33.31 26.00 28.12
PBT 51.05 99.41 -48.65 193.39 251.53 -23.11 315.28 281.17 12.13
TAX 13.03 25.57 -49.04 48.33 63.32 -23.67 78.66 70.91 10.93
Deferred Tax 0.27 0.15 80.00 1.08 0.46 134.78 1.06 -0.89 -219.10
PAT 38.02 73.84 -48.51 145.06 188.21 -22.93 236.62 210.26 12.54
Equity 82.64 82.64 0.00 82.64 82.64 0.00 82.64 82.64 0.00
PBIDTM(%) 16.81 24.01 -29.97 19.28 22.93 -15.92 21.96 21.85 0.50

Titan Bio-Tech Share Price

484.70 -11.45 (-2.31%)
05-May-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3628.65
Tata Chemicals 801.15
SRF 2527.60
Pidilite Inds. 1363.45
Deepak Nitrite 1771.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×